<DOC>
	<DOC>NCT00094341</DOC>
	<brief_summary>The purpose of this study is to determine the preference of RA patients for the new Enbrel速 (etanercept) pre-filled syringe in patients who are already taking Enbrel速.</brief_summary>
	<brief_title>Preference of Rheumatoid Arthritis (RA) Patients of Enbrel速 (Etanercept) Auto-Injector Versus Enbrel速 Pre-Filled Syringes</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Have established RA diagnosis as determined by ACR criteria Be current user of etanerceptlyophilized preparation for at least 4 consecutive weeks of etanercept dosing on either a once weekly or twice weekly regimen Subject must be able to self inject Give written informed consent Subject is currently enrolled in or has not yet completed at least 30 days since ending other investigational device or drug trial(s), or subject is receiving other investigational agent(s) Subject of childbearing potential is pregnant (e.g., positive HCG test) or is breastfeeding Elective surgery is planned during study period Subjects allergic to latex</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Arthritis</keyword>
	<keyword>Rheumatology</keyword>
</DOC>